These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 12387040)

  • 1. [Insulin aspart].
    Namba M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():492-7. PubMed ID: 12387040
    [No Abstract]   [Full Text] [Related]  

  • 2. Impaired absorption of insulin aspart from lipohypertrophic injection sites.
    Johansson UB; Amsberg S; Hannerz L; Wredling R; Adamson U; Arnqvist HJ; Lins PE
    Diabetes Care; 2005 Aug; 28(8):2025-7. PubMed ID: 16043749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Inhaled insulin].
    Uchigata Y
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():534-41. PubMed ID: 12387047
    [No Abstract]   [Full Text] [Related]  

  • 4. [Insulin lispro].
    Matsuda A
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():485-91. PubMed ID: 12387039
    [No Abstract]   [Full Text] [Related]  

  • 5. Intensifying insulin therapy with insulin analog premixes: transitioning from basal insulin in type 2 diabetes.
    Shanik MH
    Diabetes Technol Ther; 2012 Jun; 14(6):533-9. PubMed ID: 22364142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Insulin aspart(NN-X14)].
    Namba M
    Nihon Rinsho; 2001 Nov; 59(11):2144-50. PubMed ID: 11712399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and pharmacodynamics of different modes of insulin pump delivery. A randomized, controlled study comparing subcutaneous and intravenous administration of insulin aspart.
    Ihlo CA; Lauritzen T; Sturis J; Skyggebjerg O; Christiansen JS; Laursen T
    Diabet Med; 2011 Feb; 28(2):230-6. PubMed ID: 21219436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical aspects of Insulin Lispro (LY275585)].
    Kuzuya T
    Nihon Rinsho; 1997 Nov; 55 Suppl():298-305. PubMed ID: 9434484
    [No Abstract]   [Full Text] [Related]  

  • 9. [Recent progress in insulin therapy].
    Tajuma N
    Nihon Naika Gakkai Zasshi; 2006 Sep; 95(9):1888-94. PubMed ID: 17037332
    [No Abstract]   [Full Text] [Related]  

  • 10. [Insulin lispro].
    Matsuda A
    Nihon Rinsho; 2001 Nov; 59(11):2140-3. PubMed ID: 11712398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin aspart. Asp-B28, NovoRapid.
    Drugs R D; 1999 Aug; 2(2):103-6. PubMed ID: 10820650
    [No Abstract]   [Full Text] [Related]  

  • 12. Insulin aspart.
    Simpson KL; Spencer CM
    Drugs; 1999 May; 57(5):759-65; discussion 766-7. PubMed ID: 10353301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Intensified insulin therapy. Is there an alternative to BE count?].
    MMW Fortschr Med; 2006 Sep; 148(37):21. PubMed ID: 17036898
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized trial comparing continuous subcutaneous insulin infusion of insulin aspart versus insulin lispro in children and adolescents with type 1 diabetes.
    Weinzimer SA; Ternand C; Howard C; Chang CT; Becker DJ; Laffel LM;
    Diabetes Care; 2008 Feb; 31(2):210-5. PubMed ID: 17989308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of age of infusion site and type of rapid-acting analog on pharmacodynamic parameters of insulin boluses in youth with type 1 diabetes receiving insulin pump therapy.
    Swan KL; Dziura JD; Steil GM; Voskanyan GR; Sikes KA; Steffen AT; Martin ML; Tamborlane WV; Weinzimer SA
    Diabetes Care; 2009 Feb; 32(2):240-4. PubMed ID: 19017777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of treatment satisfaction associated with the use of insulin aspart in continuous subcutaneous insulin infusion.
    Wittlin SD; Marcus AO; Weng CS; Howard CP; Schorr AB;
    Diabetes Technol Ther; 2008 Feb; 10(1):1-10. PubMed ID: 18275357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular effects of rapid-acting insulin analogs in the diabetic patient: a review.
    Fordan S; Raskin P
    Vasc Health Risk Manag; 2009; 5(1):225-31. PubMed ID: 19436644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Long-term clinical application of wearable artificial endocrine pancreas].
    Konno Y; Nishida K; Shimoda S; Sakakida M; Shichiri M
    Nihon Rinsho; 1997 Nov; 55 Suppl():282-7. PubMed ID: 9434481
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of biphasic insulin aspart in patients with type 2 diabetes.
    Halimi S; Raskin P; Liebl A; Kawamori R; Fulcher G; Yan G
    Clin Ther; 2005; 27 Suppl B():S57-74. PubMed ID: 16519038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Visualization of Blood Glucose Fluctuations Using Continuous Glucose Monitoring in Patients Undergoing Hemodialysis.
    Mori K; Emoto M; Abe M; Inaba M
    J Diabetes Sci Technol; 2019 Mar; 13(2):413-414. PubMed ID: 30580579
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.